Litcius/Paper detail

POS1046 DEUCRAVACITINIB LONG-TERM EFFICACY AND SAFETY IN PLAQUE PSORIASIS: 2-YEAR RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM

Richard B. Warren, H. Sofen, S. Imafuku, J. Szepietowski, A. Blauvelt, L. Spelman, E. Colston, J. Toms, A. Buck, S. Banerjee, A. Menter

2022Annals of the Rheumatic Diseases12 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePsoriasisTolerabilityPlaceboPsoriatic arthritisApremilastInternal medicineAdverse effectClinical trialImmunologyPathologyAlternative medicinePsoriasis: Treatment and PathogenesisCytokine Signaling Pathways and InteractionsAutoimmune Bullous Skin Diseases
POS1046 DEUCRAVACITINIB LONG-TERM EFFICACY AND SAFETY IN PLAQUE PSORIASIS: 2-YEAR RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM | Litcius